Menu
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Earnings Preview: Halliburton (HAL) Q3 Earnings Expected to Decline
Earnings Preview: Halliburton (HAL) Q3 Earnings Expected to Decline

The market expects Halliburton (HAL) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for

The market expects Elevance Health (ELV) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Bridgewater (BWB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Bridgewater (BWB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Bridgewater (BWB) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Coca-Cola (KO) Earnings Expected to Grow: Should You Buy?
Coca-Cola (KO) Earnings Expected to Grow: Should You Buy?

Coca-Cola (KO) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook

Philip Morris (PM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Philip Morris (PM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Wall Street expects a year-over-year increase in earnings on higher revenues when Philip Morris (PM) reports results for the quarter ended September 2025. While this widely-known consensus outlook

Chubb (CB) Earnings Expected to Grow: Should You Buy?
Chubb (CB) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Chubb (CB) reports results for the quarter ended September 2025. While this widely-known consensus outlook is

General Motors (GM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
General Motors (GM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

General Motors (GM) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook

SmarFinancial (SMBK) Earnings Expected to Grow: Should You Buy?
SmarFinancial (SMBK) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when SmarFinancial (SMBK) reports results for the quarter ended September 2025. While this widely-known consensus

GE Aerospace (GE) Reports Next Week: Wall Street Expects Earnings GrowthPhoto, wide shot, wide-angle lens,  Logistics company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/a16a79c7-f73c-405d-ba63-e8d69b66ce4e.png
GE Aerospace (GE) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when GE Aerospace (GE) reports results for the quarter ended September 2025. While this widely-known consensus outlook

Nasdaq (NDAQ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Nasdaq (NDAQ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Nasdaq (NDAQ) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Earnings Preview: Manhattan Associates (MANH) Q3 Earnings Expected to Decline
Earnings Preview: Manhattan Associates (MANH) Q3 Earnings Expected to Decline

Manhattan Associates (MANH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Earnings Preview: Matador Resources (MTDR) Q3 Earnings Expected to Decline
Earnings Preview: Matador Resources (MTDR) Q3 Earnings Expected to Decline

The market expects Matador Resources (MTDR) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known

Citigroup (C) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Citigroup (C) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Citigroup (C) reported revenue of $22.09 billion, up 8.7% over the same period last year. EPS came in at $2.24, compared to $1.51 in the year-ago quarter.

The

Best Momentum Stock to Buy for Oct. 14thPhoto, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Best Momentum Stock to Buy for Oct. 14th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Oct. 14th:

HudBay Minerals HBM: This mining company, which is engaged in discovery

Wall Street Analysts Believe Relay Therapeutics (RLAY) Could Rally 116.91%: Here's is How to Trade
Wall Street Analysts Believe Relay Therapeutics (RLAY) Could Rally 116.91%: Here's is How to Trade

Shares of Relay Therapeutics, Inc. (RLAY) have gained 54.4% over the past four weeks to close the last trading session at $6.27, but there could still be a solid upside left in the stock if

Wall Street Analysts Believe Mobileye (MBLY) Could Rally 25.86%: Here's is How to Trade
Wall Street Analysts Believe Mobileye (MBLY) Could Rally 25.86%: Here's is How to Trade

Shares of Mobileye Global (MBLY) have gained 10.2% over the past four weeks to close the last trading session at $15.2, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a BetPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a Bet

Shares of Kiniksa Pharmaceuticals International, plc (KNSA) have gained 1.3% over the past four weeks to close the last trading session at $37.03, but there could still be a solid upside left in the

Does Kamada (KMDA) Have the Potential to Rally 114.39% as Wall Street Analysts Expect?
Does Kamada (KMDA) Have the Potential to Rally 114.39% as Wall Street Analysts Expect?

Kamada (KMDA) closed the last trading session at $6.88, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Wall Street Analysts Predict a 30.28% Upside in Kodiak Gas (KGS): Here's  What You Should Know
Wall Street Analysts Predict a 30.28% Upside in Kodiak Gas (KGS): Here's What You Should Know

Kodiak Gas Services (KGS) closed the last trading session at $34.05, gaining 2.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

How Much Upside is Left in Exodus Movement, Inc. (EXOD)? Wall Street Analysts Think 98.53%
How Much Upside is Left in Exodus Movement, Inc. (EXOD)? Wall Street Analysts Think 98.53%

Shares of Exodus Movement, Inc. (EXOD) have gained 2.7% over the past four weeks to close the last trading session at $28.64, but there could still be a solid upside left in the stock if short-term

Wall Street Analysts Believe Eupraxia Pharmaceuticals Inc. (EPRX) Could Rally 85.12%: Here's is How to TradePhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Wall Street Analysts Believe Eupraxia Pharmaceuticals Inc. (EPRX) Could Rally 85.12%: Here's is How to Trade

Eupraxia Pharmaceuticals Inc. (EPRX) closed the last trading session at $6.05, gaining 14.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Princeton Bancorp (BPRN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Princeton Bancorp (BPRN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

A downtrend has been apparent in Princeton Bancorp (BPRN) lately. While the stock has lost 7.9% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed in

Here's Why Bank of Marin (BMRC) Looks Ripe for Bottom FishingPhoto, wide shot, wide-angle lens,  Bank, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/3aa597ca-f944-4a9b-bf8d-3071f3b5a5c9.png
Here's Why Bank of Marin (BMRC) Looks Ripe for Bottom Fishing

The price trend for Bank of Marin (BMRC) has been bearish lately and the stock has lost 5% over the past four weeks. However, the formation of a hammer chart pattern in its last trading session

Wall Street Analysts Predict a 36.47% Upside in Select Medical (SEM): Here's  What You Should KnowPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Wall Street Analysts Predict a 36.47% Upside in Select Medical (SEM): Here's What You Should Know

Shares of Select Medical (SEM) have gained 7.8% over the past four weeks to close the last trading session at $13.19, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Predict a 42.77% Upside in DarioHealth (DRIO): Here's  What You Should Know
Wall Street Analysts Predict a 42.77% Upside in DarioHealth (DRIO): Here's What You Should Know

DarioHealth Corp. (DRIO) closed the last trading session at $14.94, gaining 124% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by